CLDN16 and familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis: Other studies comprising FHHNC patients with complete loss of function of claudin-16 reported the median age of the first symptoms ranging from 0.1 to 7 years, and the age of clinical diagnosis ranging from 0.5 to 12 years [1, 12, 22, 23].